A total of 2425 patients were randomised and received at least one dose of study
medicine(s) in this study. The table below shows the gender and age of these patients.
Patients who were randomised and received at least one dose of
study medicine(s)
Umeclidinium and Umeclidinium Salmeterol
vilanterol
812 patients 804 patients 809 patients
Gender
Female 319 (39%) 327 (41%) 342 (42%)
Male 493 (61%) 477 (59%) 467 (58%)
Age - in years
Range 41 to 89 41 to 89 40 to 92
Average 65 65 64
Where was this study done?
Study sites were in 12 countries.
Number of patients who received at least one dose of
study medicine(s) in each country
Argentina 549
Australia 35
Canada 83
France 36
Germany 645
Italy 77
Mexico 35
Netherlands 37
South Africa 63
Spain 78
Sweden 109
United States 678
0 100 200 300 400 500 600 700 800
Number of patients